Tuesday, July 16, 2024

AUTHOR NAME

Zahra Ahangar Atashi

712 POSTS
0 COMMENTS

Mitral Valve Innovations: Affluent Medical and Edwards Lifesciences Forge Groundbreaking Agreements

Affluent Medical, a prominent French clinical-stage medical technology company specializing in innovative medical devices, has announced a series of significant agreements with Edwards Lifesciences,...

Call for Simplification of Clinical Trial Regulations to Enhance Safety

Researchers Dr. Ulrike Lorch, co-founder and Chief Medical Director at Richmond Pharmacology, and Professor Charles Vincent of Oxford University and Imperial College London, have...

MIRA Pharmaceuticals Announces Promising Results for MIRA-55 in Preclinical Tests

MIRA Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, has revealed promising preclinical results for its innovative oral pharmaceutical marijuana analog, MIRA-55. The new data substantiates...

Insulin Delivery Technology: Modular Medical and Gubra Study Personalized Metabolic Therapy

Modular Medical, a pioneering company in insulin delivery technology, has announced an exciting new proof-of-concept study in collaboration with Gubra A/S. This study will...

Artificial Intelligence and Machine Learning Medical Device Market Report Predicts Significant Growth

InsightAce Analytic Pvt. Ltd. has announced the release of a comprehensive market assessment report on the Global Artificial Intelligence/Machine Learning Medical Device Market. This...

Diabetes Distress Targeted in £3 Million D-Stress Program by Diabetes UK and NIHR

Diabetes UK and the National Institute for Health Research (NIHR) are collaborating in a nearly £3 million investment into research aimed at identifying, treating,...

Antibiotic Use Reduced by Over-the-Counter Nasal Sprays, Study Finds

Antibiotic use is reduced by over-the-counter nasal sprays, which are effective at lessening the symptoms and duration of flu and colds, especially in at-risk...

Uterine Cancer Drug Reimbursed from Basic Package by Healthcare Institute

Uterine cancer treatment with the drug dostarlimab (Jemperli®) has been recommended by the Netherlands Healthcare Institute for inclusion in the basic health insurance package...

Medicine Proposal by Pharmac to Increase Access for Cancer and Other Health Conditions

Medicines for various cancers, including kidney and lung cancers, as well as other health conditions, are being targeted for increased access by Pharmac –...

Surgical Procedures Revolutionized by ImmersiveTouch’s FDA-Cleared AR System

Surgical procedures benefit from ImmersiveTouch's U.S. Food and Drug Administration (FDA) clearance of its augmented reality (AR) system, designed to enhance craniomaxillofacial surgeries and...

Latest news